$26.78
-0.61-2.23%
Last update: Nov 5, 10:37 AM
Alamar Biosciences Inc
ALMRNASDAQ
The average analyst price target for Alamar Biosciences is $34.50, 28.8% above the current price. Of 4 analysts, 4 rate it Buy. Targets range from $32 to $36. The latest change came on Nov 4, 2026, when TD Cowen raised its price target on Alamar Biosciences from $34 to $36 and kept a Buy rating.
Price Target Range — 3 Quarters
Analyst Consensus — 4 Analysts
Rating Trend — Last 9 Months
